Objective: To explore the association of promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene with obesity. Subjects: In total, 213 nondiabetic Japanese subjects. They were divided into three groups according to World Health Organization definitions: lean (body mass index (BMI) o25 kg/m Methods: We examined two polymorphic loci in the MIF gene in the subjects: a single-nucleotide polymorphism at position À173 (G/C) and a CATT-tetranucleotide repeat polymorphism at position À794, which both can affect promoter activity in different cells. Results: We detected four alleles: 5-, 6-, 7-and 8-CATT at position À794. Genotypes without the 5-CATT allele (X/X, X refers to 6-, 7-or 8-CATT alleles) were more common in obese subjects than in lean or overweight groups (P ¼ 0.013). The X-CATT allele was more frequent in obese subjects than in lean or overweight subjects (P ¼ 0.030). In contrast, À173G/C was not associated with obesity. Among the haplotypes of the two promoter polymorphisms, G/5-CATT ((À173G/C)/(À794[CATT] 5-8 )) was associated with a decreased risk of obesity (P ¼ 0.025) and G/6-CATT with an increased risk of overweight (P ¼ 0.028). Conclusion: Promoter polymorphism in the MIF gene is linked with obesity.
Introduction
Obesity is a risk factor for a wide variety of diseases, including type 2 diabetes and cardiovascular diseases. Because the morbidity of these diseases is increasing, obesity is a serious health problem in Western countries and also in Japan. A high-calorie diet and a sedentary lifestyle contribute to the development of obesity. However, in addition to these environmental factors, genetic factors also play an important role in adiposity. In a literature review, heritability of body mass index (BMI) was estimated to be between 50 and 90%. 1 Associations between BMI and gene polymorphisms have been also reported and have provided useful information, although such findings have yet to account for the entire genetic contribution to obesity.
Macrophage migration inhibitory factor (MIF) is a multifunctional molecule. As MIF is generally recognized as a proinflammatory cytokine 2 and obesity is associated with a chronic inflammatory response, 3 MIF may have an impact on the pathophysiology of obesity. Although MIF was first discovered as a cytokine secreted by lymphocytes, it is expressed ubiquitously, is secreted by the pituitary gland as a hormone, and works as an enzyme. 4 MIF is also produced by pancreatic beta cells and acts as a positive regulator of insulin secretion when the cells are stimulated with glucose. 5 Furthermore, MIF expressed in muscle has a catabolic effect via induction of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase. 6 MIF is also expressed in adipose tissue and is upregulated by glucose and insulin. 7, 8 These findings led us to hypothesize that MIF is linked with energy metabolism. Indeed, it was shown that plasma MIF concentration is positively correlated with BMI. 9 The MIF gene is located on chromosome 22q11.23, which was linked to an accumulation of abdominal subcutaneous fat in Caucasians in a genome-wide linkage scan. 10 Although this finding was not replicated in other populations, it is possible that 22q11.23 is a susceptibility locus for abdominal adiposity in a particular population. Two polymorphisms are known to exist in the promoter region of the MIF gene, a tetranucleotide CATT repeat located at position À794 (À794[CATT] [5] [6] [7] [8] ) and a single-nucleotide G/C substitution located at position À173 (À173G/C). 11, 12 The polymorphisms at À794 and at À173 were shown to be associated with severity of rheumatoid arthritis and with risk of systemiconset juvenile idiopathic arthritis, respectively. Both the polymorphism and haplotypes of the two polymorphisms were also associated with atopy and psoriasis. 13, 14 These polymorphisms affect MIF promoter activity in vitro.
11,15
Here, we document the significant associations between MIF gene polymorphism and obesity in Japanese.
Subjects and methods

Subjects
Subjects were recruited from among individuals who had requested annual medical checkups (n ¼ 142) or those who agreed to be volunteers (n ¼ 71). Obese students of Hokkaido University, who were called for a physical examination, were also recruited into the study (n ¼ 10). All subjects provided written informed consent. MIF gene polymorphism analysis Total DNA was extracted from peripheral blood leukocytes using a SepaGene kit (Sanko Pharmaceutical Co., Tokyo, Japan). Polymorphism at À794 was analyzed as described previously. 11 Briefly, DNA was amplified by PCR using a forward primer, 5 0 -TGCAGGAACCAATACCCATAGG, and a reverse primer labeled with FAM, 5 0 -AATGGTAAACTCGGG GAC. The PCR products and GS-500 TAMRA size standard (Perkin-Elmer-Applied Biosystems, CA, USA) were analyzed with an ABI 310 Genetic Analyzer (Perkin Elmer-Applied Biosystems). The sizes of PCR products were 340, 344, 348 and 352 bp in length and these corresponded to 5-, 6-, 7-, and 8-CATT repeats, respectively. Genotypes were analyzed using Genescan software (Perkin Elmer-Applied Biosystems). Polymorphism at À173G/C was typed using real-time quantitative PCR with allele-specific primers that specifically amplified either the À173G or À173C allele in separate PCR runs, as described previously. 13 PCR products were detected using the ABI 7700 Sequence Detection System with the dsDNA-specific fluorescent dye SYBR Green I (PE Applied Biosystems).
Statistical analysis
The proportions of genotypes or alleles were compared by w 2 analysis. Odds ratios (ORs) and 95% confidence interval (CI) were calculated by logistic regression analysis adjusted for age and sex. Significance was defined as Po0.05. In order to verify whether the numbers of each genotype were in Hardy-Weinberg equilibrium, we used the HWE program. 16 Association between the haplotype and obesity was analyzed using the Haplo Stats program. 17 Haplotype frequencies for each group were computed using the haplo.group function of the program. Haplotype-specific score was calculated using the haplo.score function of the program. Negative haplotype-specific scores are associated with a protective effect and positive haplotype-specific scores are associated with an increased risk.
Results
The frequency of the 5-, 6-, 7-and 8-CATT alleles located at À794 of MIF gene was 40.6, 41.3, 17.8 and 0.2%, respectively. The frequency of G and C allele at position À173 was 76.1 and 23.9%, respectively. Genotype frequencies were in Hardy-Weinberg equilibrium at both loci (
Because it was reported that the transcriptional activity of the MIF promoter with the 5-CATT repeat was lower than that with other alleles at À794[CATT] 5-8 , 11 we classified the subjects into two groups; subjects with the 5-CATT allele (5/5 and 5/X) and those without the 5-CATT allele (X/X) (X indicates 6-, 7-or 8-CATT allele). The X/X genotype was more common in obese subjects than in lean or overweight groups (Table 1 , P ¼ 0.013). Subjects with the X/X genotype were at increased risk for obesity when compared with those having the 5-CATT allele adjusted by age and sex (OR 2.85, 95% CI 1.19-6.80, P ¼ 0.018). Based on the prevalence of obesity and its associated complications in Japanese, the Japan Society for the Study of Obesity (JASSO) has defined BMIs of 25 kg/m 2 or higher as 'obese'. 18 When the Japanese criterion was applied, the risk of obesity (having BMI of X25 kg/m 2 ) in subjects with the X/X genotype was also increased (OR 2.05, 95% CI 1.12-3.78, P ¼ 0.021). We found that the X-CATT allele was more frequent in obese subjects than in lean subjects (Table 1 , P ¼ 0.030). As obesity is a risk factor of glucose intolerance, we compared the results of 75 g OGTT in each genotype. The proportion of individuals with impaired glucose tolerance (IGT) based on the WHO criteria tended to be higher in those with the X/X genotype when adjusted by age and sex (OR 2.032, 95% CI 0.976-4.230, P ¼ 0.0581). We found no association between À173G/C genotypes and obesity (Table 2) . When adjusted for age and sex, the OR for obesity in individuals with the C allele was 1.312 and 95% CI was 0.562-3.065 (P ¼ 0.531).
We then analyzed the haplotype of the À794[CATT] 5-8 and À173G/C ( Table 3 ). The G/5-CATT ((À173G/C)/ MIF promoter polymorphism and obesity S Sakaue et al (À794[CATT] 5-8 )) haplotype was associated with a decreased risk of obesity, as judged by haplotype-specific scores after adjusting for age and sex based on 1000 simulations (P ¼ 0.026). The G/6-CATT haplotype tended to increase the risk of obesity, but not significantly (P ¼ 0.055). When the Japanese criterion was applied (cutoff BMI value ¼ 25), the G/ 6-CATT haplotype was significantly associated with obesity (P ¼ 0.028) in haplo.score (Table 3) .
Discussion
In the present study, we demonstrated that MIF À794[CATT] 5-8 was associated with obesity in a Japanese population. Increased risk of obesity was identified in the subjects with the X-CATT allele. Another polymorphism in the MIF promoter region, À173G/C, was not associated with obesity. However, the G/5-CATT haplotype of the two loci was associated with a reduced risk of obesity, while G/6-CATT was associated with an increased risk of obesity.
The Although MIF may function as a direct regulator of energy metabolism, it may affect adiposity as a pro-inflammatory mediator. Abnormal production of inflammatory cytokines, such as increased tumor necrosis factor (TNF)-a, in adipose tissue has been found in obese rodents and humans. 19, 20 This dysregulation of cytokines could contribute, at least in part, to the insulin resistance caused by obesity. 21 In addition, it is also possible that insulin resistance per se might involve the development of obesity. 22, 23 Aberrant production of TNF-a in adipose tissue may inhibit insulin from promoting adipocyte triglyceride stores or adipocyte differentiation. Indeed, gene polymorphisms of TNF have been associated with obesity by many investigators. [24] [25] [26] [27] [28] [29] [30] [31] Infiltrative macrophages have been shown to be increased and to be the main source of TNF-a expression in adipose tissue in obese mice. 32, 33 MIF could upregulate TNF-a secretion by macrophages. 34 It was recently demonstrated that MIF secretion from adipocytes is correlated with BMI. 35 Taken together, these results suggest that MIF may contribute to obesity via regulation of inflammatory cytokine production in adipose tissue. In contrast to À794[CATT] 5-8 , the À173G/C polymorphism was not associated with obesity, although both polymorphisms exert an effect on MIF promoter activity. 15 The two polymorphisms have genetic effects on promoter activity through interactions in vitro, 36 and thus, a genetic function of the promoter polymorphisms should be considered with regard to haplotype. The estimated frequency of the three major haplotypes (G/5-CATT, G/6-CATT and C/7-CATT) was about 93% in the present study due to the strong linkage disequilibrium between the two polymorphisms. 13, 15 Haplotypes G/5-CATT and G/6-CATT, which both carry the G allele at À173 and are common in the Japanese population at similar frequencies, had opposite effects on obesity risk, while C/7-CATT had no effect. Thus, single-locus analysis for The diversity of haplotype frequency by subject may affect the result of À173G/C analysis. Contrary to the results of our analysis, À173G/C polymorphisms may be found to be associated with obesity in other populations. When similar analyses are carried out in other populations, we should be able to confirm any differences in haplotype frequency and the relationships with disease state. With regard to the allele frequency of À794[CATT] 5-8 , the results of this study were not concordant with those of a previous study in Caucasians. 11 It is interesting to note that the frequency of the 5-CATT allele is higher in the Japanese population (Japanese (this study), 40.6%; Caucasian, 27.7% 11 ), among which the prevalence of obesity is lower than in Europe and the USA. 18 In juvenile idiopathic arthritis, À173G/C clearly influences susceptibility, 15 and considering the linkage disequilibrium, haplotype C/7-CATT may be associated with this disease. 36 In other studies, phenotypes associated with À173G/C were also associated with haplotype C/7-CATT. 13, 37 If the effects of haplotype C/7-CATT on MIF promoter activity were universal, our results would be incongruent. However, the effects of the haplotype are cell type-specific, 13, 36, 37 and in obesity-related cells, G/5-CATT and G/6-CATT may affect promoter activity more potently than C/7-CATT. A limitation of the present study was the small number of obese subjects. In view of the low proportion of obesity in the present study, a case-control study on a larger scale is required to conclusively determine the effects of MIF promoter polymorphism on obesity.
We demonstrated that the promoter region of the MIF gene is associated with obesity. Our results suggest that MIF plays an important role in energy balance. MIF promoter polymorphism and obesity S Sakaue et al
